HomeOwner Search
Visit USCO2017
Category SearchNavidea Enters Lymphoseek Development and Commercialization Agreement for China
![hero image](/_next/image?url=%2Fimages%2FCRLogo.png&w=384&q=75)
Text Registration
Copyright Title
Navidea Enters Lymphoseek Development and Commercialization Agreement for China
Status
Published
on 9 May 2017
Year of Creation
2014
Copyright Claimant
Navidea Biopharmaceuticals, Inc
Registration Number
TX0008338882
on 9 May 2017Copyright Summary
The U.S. Copyright record (Registration Number: TX0008338882) dated 9 May 2017, pertains to an electronic file (eService) titled "Navidea Enters Lymphoseek Development and Commercialization Agreement for China" created in 2014. The copyright holder is Navidea Biopharmaceuticals, Inc, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Navidea Biopharmaceuticals, Inc.
Application Details
Registration Number
TX0008338882
Registration Date
5/9/2017
Year of Creation
2014
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Navidea Biopharmaceuticals, Inc
Physical Description
Electronic file (eService)
First Publication Nation
United States
Preexisting Material
artwork, non-body text
Notes
Rights Note: PORZIO, BROMBERG & NEWMAN, P.C., 1200 New Hampshire Avenue, NW, Suite 710, Washington, DC, 20036, United States
Material Matter Claimed Note: text
Statements
Application Title Statement: Navidea Enters Lymphoseek Development and Commercialization Agreement for China
Author Statement: Navidea Biopharmaceuticals, Inc employer for hire Domicile: United States Citizenship: United States Authorship: text
© 2023 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.